Le Lézard
Classified in: Science and technology
Subject: Product/Service

GroupSense Awarded Patent for Systems and Methods for Detecting and Remedying Theft of Data


GroupSense, a digital risk protection services (DRPS) company, today announced that the United States Patent and Trademark Office (USPTO) has issued a patent for their systems and methods for detecting and remedying the theft of data. The patent covers GroupSense's approach to finding and removing stolen client data from the deep, dark, and open web.

GroupSense's patented research and removal method reduces the risk of cybersecurity incidents, breaches, and ransomware by taking stolen data off the dark web before threat actors can use it to hurt an organization. This patented technology gives GroupSense a significant advantage in the fight against cyber crime.

"We are thrilled to receive this patent, which validates our comprehensive approach to cybersecurity," said Adam Bregenzer, chief technology and product officer at GroupSense. "This patent further proves our ability to proactively protect our clients from cyber attacks; preventing business interruption, revenue loss, and reputational damage."

While finding stolen data on the web is part of any digital risk protection service, it's not enough to just alert organizations to illicit online activity. This patent reinforces the importance of driving digital risk mitigation and tangible outcomes from the negative business outcomes associated with cybersecurity incidents. By removing data from its source, GroupSense goes a step beyond competitors by eliminating the risk of threat actors misusing or reselling that data to other actors instead of just alerting the victim.

GroupSense combines automated and human reconnaissance to deliver customer-specific intelligence to improve enterprise cybersecurity. Among the services GroupSense offers are Digital Risk Protection, Election Threat Protection, Executive Protection and Ransomware services.

About GroupSense

GroupSense is a digital risk protection services company that delivers customer-specific intelligence that dramatically improves cybersecurity and fraud-management operations. Unlike generic cyber intelligence vendors, GroupSense uses automated and human reconnaissance to create finished intelligence that maps to each customer's specific digital business footprint and risk profile. This enables customers to immediately use GroupSense's intelligence to reduce enterprise risk, without requiring additional processing or management by overstretched security and fraud-prevention teams. GroupSense is based in Arlington, Va., with a growing customer base that includes large enterprises, state and municipal governments, law enforcement agencies, and more.


These press releases may also interest you

at 00:45
Claudio Bono, Managing Director for two independent Hotels in Silicon Valley, is thrilled to unveil a groundbreaking platform and an idea that will transform the landscape of the urgent unhoused crisis and social issues. Leveraging his extensive...

26 avr 2024
OKX, a leading Web3 technology company, today announced the integration of Side Protocol with the OKX Wallet. Side Protocol is a cross-chain middleware protocol designed to enable seamless communication and asset transfer between heterogeneous...

26 avr 2024
OKX, a leading Web3 technology company, today announced the integration of Biturbo with the OKX Wallet. Bitrubo is an innovative layer 2 solution that brings the power of Ethereum's smart contracts to the Bitcoin network. Biturbo is designed as an...

26 avr 2024
The report titled "Cognitive Security Market by Component (Services, Solutions), Security Type (Application, Cloud, Cybersecurity), Application, Deployment Mode, Enterprise Type, Vertical - Global Forecast 2024-2030" is now available on...

26 avr 2024
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

26 avr 2024
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...



News published on and distributed by: